ACTRN12614000781640
Active, not recruiting
Phase 1
A proof-of-concept study to assess the effect of ACT-451840 against early Plasmodium falciparum blood stage infection in healthy subjects
James McCarthy0 sites8 target enrollmentJuly 21, 2014
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Malaria
- Sponsor
- James McCarthy
- Enrollment
- 8
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy volunteers
Exclusion Criteria
- •Any history of malaria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A proof of concept study to evaluate the impact of a food supplement on uptake and anti-inflammatory properties of omega-3 fatty acid derived specialized pro-resolution lipid mediatorsHealthy volunteersDRKS00023304Evonik Operations GmbH19
Completed
Not Applicable
A proof of concept study to evaluate the impact of a food supplement on production of short chain fatty acids and microbiome in healthy subjectshealthy volunteersDRKS00023166Evonik Operations GmbH18
Completed
Not Applicable
A Randomised, Double-blinded, Placebo-controlled Study of the probiotic PCC(Registered Trademark) (L. fermentum VRI-003) capsule for the effect on gastrointestinal health and gut microflora in healthy adults (with no medically diagnosed gastrointestinal disease)Gastrointestinal healthOral and Gastrointestinal - Normal oral and gastrointestinal development and functionACTRN12616001052426Bioxyne Limited60
Completed
Not Applicable
Prospective study to assess the effectiveness of an integrative primary care approach versus standard primary care management of chronic musculoskeletal pain.NL-OMON36897ouis Bolk Instituut268
Completed
Not Applicable
Add-on salmeterol versus montelukast in Arg/Arg-16 asthmaticsISRCTN49849003niversity of Dundee (UK)120